Optical disk drive and information recording method
    11.
    发明申请
    Optical disk drive and information recording method 审中-公开
    光盘驱动器和信息记录方法

    公开(公告)号:US20050141394A1

    公开(公告)日:2005-06-30

    申请号:US10938923

    申请日:2004-09-13

    申请人: Mitsuo Yamazaki

    发明人: Mitsuo Yamazaki

    CPC分类号: G11B7/1263 G11B7/0045

    摘要: An optical disk drive of the present invention has a controller, which obtains saturation levels of a first reflected laser beam obtained by a laser beam with a playback light intensity and a second reflected laser beam obtained by a laser beam with a recording light intensity, in a signal processing circuit, based on the results of detecting the first and second reflected laser beams by a detector, computes the intensity of a recording laser beam output from a light source based on the saturation levels of the reflected laser beams specified by a signal processing means, and instructs a laser driving circuit to drive a laser driving signal capable of achieving the intensities of playback and recording laser beams based on the computation results.

    摘要翻译: 本发明的光盘驱动器具有控制器,该控制器获得通过具有回放光强度的激光束获得的第一反射激光束的饱和度水平和由具有记录光强度的激光束获得的第二反射激光束, 基于由检测器检测第一和第二反射激光束的结果的信号处理电路基于由信号处理指定的反射激光束的饱和电平计算从光源输出的记录激光束的强度 指示并且指示激光驱动电路基于计算结果驱动能够实现重放强度和记录激光束的激光驱动信号。

    Pigment dispersions for color filters, fabrication process of color filters, and color filters
    12.
    发明授权
    Pigment dispersions for color filters, fabrication process of color filters, and color filters 有权
    彩色滤光片的颜料分散体,滤色片的制造工艺和滤色片

    公开(公告)号:US06302953B1

    公开(公告)日:2001-10-16

    申请号:US09471475

    申请日:1999-12-23

    IPC分类号: C07D25100

    摘要: Pigment dispersions for color filters are composed of pigments, dispersants, film-forming resins and liquid media. The dispersants comprises compounds represented by the following formula (I): wherein X and X′ each independently represent H, OH, alkoxy, primary, secondary or tertiary amino, or acylamino; Y represents an anthraquinonylamino, phenylamino or phenoxy group having H, OH, alkoxy, primary, secondary or tertiary amino, or acylamino at the 4-position or 5-position; A and B each independently represent alkyl, cycloalkyl or aryl, and at least one of A and B has at least one substituent group containing a basic nitrogen atom; and Z represents H, CN, halogen, alkyl, alkoxy, NO2, benzoylamino or 3-benzoyl, and the 3-benzoyl group may be fused together with X to form an acridone ring. These pigment dispersions are useful for the production of color filters.

    摘要翻译: 用于滤色器的颜料分散体由颜料,分散剂,成膜树脂和液体介质组成。 分散剂包括由下式(I)表示的化合物:其中X和X'各自独立地表示H,OH,烷氧基,伯,仲或叔氨基或酰氨基; Y表示在4-位或5-位具有H,OH,烷氧基,伯,仲或叔氨基或酰基氨基的蒽醌基氨基,苯基氨基或苯氧基; A和B各自独立地表示烷基,环烷基或芳基,A和B中的至少一个具有至少一个含有碱性氮原子的取代基; Z表示H,CN,卤素,烷基,烷氧基,NO 2,苯甲酰氨基或3-苯甲酰基,3-苯甲酰基可与X一起稠合形成吖啶酮环。 这些颜料分散体可用于生产滤色器。

    Griseolic acid compounds and their use as a phosphodiesterase inhibitor
    15.
    发明授权
    Griseolic acid compounds and their use as a phosphodiesterase inhibitor 失效
    绿藻酸化合物及其作为磷酸二酯酶抑制剂的用途

    公开(公告)号:US5616600A

    公开(公告)日:1997-04-01

    申请号:US437644

    申请日:1995-05-09

    CPC分类号: C07H19/02 Y02P20/55

    摘要: A compound of the formula (I) is provided ##STR1## wherein A represents a group of the formula: ##STR2## R.sup.1 and R.sup.2 are independently hydrogen, halogen or a group of the formula --OR.sup.9 ; R.sup.9 is hydrogen, alkyl, alkylsulfonyl, haloalkylsulfonyl, arylsulfonyl or a hydroxy-protecting group; R.sup.3 and R.sup.4 are independently carbamoyl or carboxy; R.sup.5 and R.sup.6 both represent hydrogen or together represent an extra carbon-carbon bond between the carbon atoms to which they are attached; and Z represents hydrogen or unsubstituted or substituted hydroxy; or a pharmaceutically acceptable salt or ester thereof. The compounds are useful as inhibitors of phosphodiesterases.

    摘要翻译: 提供式(I)的化合物,其中A表示下式的基团:R 1和R 2独立地是氢,卤素或式-OR 9的基团; R9是氢,烷基,烷基磺酰基,卤代烷基磺酰基,芳基磺酰基或羟基保护基团; R3和R4独立地是氨基甲酰基或羧基; R5和R6都表示氢或一起代表它们所连接的碳原子之间的额外碳 - 碳键; Z表示氢或未取代或取代的羟基; 或其药学上可接受的盐或酯。 这些化合物可用作磷酸二酯酶的抑制剂。

    Griseolic acid derivatives
    16.
    发明授权
    Griseolic acid derivatives 失效
    灰黄酸衍生物

    公开(公告)号:US5556975A

    公开(公告)日:1996-09-17

    申请号:US437634

    申请日:1995-05-09

    CPC分类号: C07H19/02 Y02P20/55

    摘要: A compound of the formula (I) is provided ##STR1## wherein A represents a group of the formula: ##STR2## R.sup.1 and R.sup.2 are independently hydrogen, halogen or a group of the formula --OR.sup.9 ; R.sup.3 and R.sup.4 are independently carbamoyl or carboxy; R.sup.5 and R.sup.a both represent hydrogen or together represent an extra carbon-carbon bond between the carbon atoms to which they are attached; and R.sup.9 is hydrogen, alkyl, alkysulfonyl, haloalkylsulfonyl, arylsulfonyl or a hydroxy-protecting group; or a pharmaceutically acceptable salt or ester thereof. The compounds are useful as inhibitors of phosphodiesterases.

    摘要翻译: 提供式(I)的化合物,其中A表示下式的基团:R 1和R 2独立地是氢,卤素或式-OR 9的基团; R3和R4独立地是氨基甲酰基或羧基; R5和Ra都表示氢或一起代表它们所连接的碳原子之间的额外碳 - 碳键; 且R 9为氢,烷基,烷磺酰基,卤代烷基磺酰基,芳基磺酰基或羟基保护基团; 或其药学上可接受的盐或酯。 这些化合物可用作磷酸二酯酶的抑制剂。

    Structure of instrument panel portion for use in vehicles
    17.
    发明授权
    Structure of instrument panel portion for use in vehicles 失效
    用于车辆的仪表板部分的结构

    公开(公告)号:US5549344A

    公开(公告)日:1996-08-27

    申请号:US438667

    申请日:1995-05-10

    摘要: A base member is laid in a space portion, which is defined by an instrument panel, in a vehicle width direction over a generally entire width of the vehicle, and a plurality of ducts is integrally formed with the base member. Furthermore, a meter placing portion, on which a meter is placed, and an air bag placing portion, on which an air bas is placed, are formed on the base member, and a harness placing portion 26, on which a flat harness is placed, is also formed on the base member in the vehicle width direction. Accordingly, the base member with which the plurality of ducts is integrally formed is a separate body from the instrument panel. Even in the case where the size of the instrument panel is changed, the base member is not required to correspond to the instrument panel and, therefore, the ducts can be commonly used. Moreover, since the base member is formed with ducts each having a closed structure, in section, it has a predetermined physical strength. Since this base member is laid in the vehicle width direction over a generally entire width of the vehicle, that portion of the vehicle body where the instrument panel is arranged is increased in physical strength owing to the provision of this base member for the sake of a possible side crush or collision of the vehicle.

    摘要翻译: 基部构件被放置在由仪表板限定的空间部分中,在车辆宽度方向上在车辆的大致整体宽度上,并且多个管道与基座构件一体地形成。 此外,在基座部件上形成有放置有仪表的仪表放置部和安放有空气基座的气囊放置部,以及放置有扁平线束的线束放置部26 也在车辆宽度方向上形成在基座部件上。 因此,与多个导管一体形成的基座部件是与仪表板分开的主体。 即使在仪表板的尺寸发生变化的情况下,也不需要将基座部件与仪表板对应,所以可以通常使用导管。 此外,由于基部构件具有各自具有封闭结构的导管,所以具有预定的物理强度。 由于该基座部件在车辆的大致整个宽度上被放置在车辆宽度方向上,所以设置仪表板的车体的那部分由于设置该基座部件而增加了体力 可能的侧面挤压或车辆碰撞。

    9-Oxo-11.alpha.-methyl-15.EPSILON.-hyroxyprost-13(trans)-enoic acid
derivatives and process for the preparaion thereof
    20.
    发明授权
    9-Oxo-11.alpha.-methyl-15.EPSILON.-hyroxyprost-13(trans)-enoic acid derivatives and process for the preparaion thereof 失效
    9-氧代-11 {60-甲基-15 {69-羟基霜霉素-13(反) - 烯酸衍生物及其制备方法

    公开(公告)号:US3996263A

    公开(公告)日:1976-12-07

    申请号:US574376

    申请日:1975-05-05

    摘要: Prostanoic acid derivatives having the formula ##STR1## wherein A represents an alkylene group having from 4 to 8 carbon atoms, R.sup.1 represents an alkyl group having from one to 5 carbon atoms, R.sup.2 and R.sup.3 may be the same or different and each represents hydrogen atom or an alkyl group having from one to 4 carbon atoms and R.sup.4 represents hydrogen atom or an alkyl group having from one to 4 carbon atoms and the pharmaceutically acceptable salts thereof and also relates to a process for the preparation thereof.The compounds are useful as anti-ulcerogenic agents and may be prepared by reducing a compound having the formula ##STR2## wherein A, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are the same above and Z represents a carbonyl-protecting group to give a compound having the formula ##STR3## wherein A, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Z are the same as above and removing the carbonyl-protecting group from the latter compound.

    摘要翻译: 具有式的前列生酸衍生物,其中A表示具有4至8个碳原子的亚烷基,R 1表示具有1至5个碳原子的烷基,R 2和R 3可以相同或不同,各自表示氢原子 或具有1至4个碳原子的烷基和R 4表示氢原子或具有1至4个碳原子的烷基及其药学上可接受的盐,并且涉及其制备方法。